Efficacy and safety of hookwire-guided sentinel lymph node biopsy for breast cancer using contrast enhanced ultrasonography with Sonazoid

Efficacy and safety of hookwire-guided sentinel lymph node biopsy for breast cancer using contrast enhanced ultrasonography with Sonazoid - Hookwire-guided Sonazoid-positive sentinel lymph node biopsy for breast cancer

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000029688

Enrollment

100

Registered

2017-11-01

Start date

2017-12-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Breast cancer

Interventions

Hookwire-guided sentinel lymph node biopsy using contrast enhanced ultrasound with Sonazoid

Eligibility

Sex/Gender

Female

Inclusion criteria

Inclusion criteria: cT1-3N0M0 breast cancer patients performance status 0-1 20 years old <= and < 90 years old informed consent has been obtained

Exclusion criteria

Exclusion criteria: egg allergy asthma during or possibility of pregnancy It seems not eligible for the present study

Design outcomes

Primary

Measure	Time frame
Concordance of the results between Sonazoid positive sentinel nodes and blue dye positive sentinel nodes	—

Countries

Japan

Contacts

Public ContactTomohiro Miyake

Osaka University Graduate School of Medicine Breast and Endocrine surgery

t_miyake@onsurg.med.osaka-u.ac.jp06-6879-3772

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026